SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 251 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $44,378,000 | +7998.2% | 256,800 | +5330.3% | 1.13% | +9308.3% |
| Q4 2014 | $548,000 | -86.2% | 4,729 | -85.4% | 0.01% | -90.7% |
| Q2 2014 | $3,984,000 | +310.7% | 32,399 | +246.1% | 0.13% | +360.7% |
| Q1 2014 | $970,000 | -85.6% | 9,362 | -87.5% | 0.03% | -83.5% |
| Q4 2013 | $6,750,000 | +278.4% | 75,049 | +181.3% | 0.17% | +325.0% |
| Q3 2013 | $1,784,000 | -71.8% | 26,678 | -72.1% | 0.04% | -76.6% |
| Q2 2013 | $6,330,000 | – | 95,687 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |